Oded Gilboa and Oz Adler Appointed to Board of Directors Toronto, Ontario–(Newsfile Corp. – September 2, 2021) – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, today announces that all resolutions were duly passed by shareholders at the Company’s Annual and Special Meeting held on September 1, 2021. “I am pleased to welcome Oz and Oded to our Board of Directors. Together, they bring decades of experience in corporate finance and accounting